| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Mar 02, 2023 | Option Exercise | $0.59 | 1,094,287 | 642,346 | 950,950 | Mar 06, 2023, 08:43 PM | |
| SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Feb 21, 2023 | Sale | $0.59 | 53,727 | 31,554 | 553,073 | Feb 23, 2023, 07:35 PM | |
| OREX | Orexigen Therapeutics, Inc. | Cannell Thomas R | EVP, COO, Pres Global Com Prod | May 31, 2017 | Option Exercise | $1.55 | 2,119 | 3,284 | 3,882 | Jun 02, 2017, 04:33 PM | |
| OREX | Orexigen Therapeutics, Inc. | Cannell Thomas R | EVP, COO, Pres Global Com Prod | Nov 30, 2016 | Option Exercise | $1.67 | 291 | 486 | 1,763 | Dec 02, 2016, 05:09 PM | |
| OREX | Orexigen Therapeutics, Inc. | Cannell Thomas R | EVP, Chief Commercial Officer | May 31, 2016 | Option Exercise | $0.34 | 9,632 | 3,275 | 14,723 | Jun 02, 2016, 11:22 AM | |
| OREX | Orexigen Therapeutics, Inc. | Cannell Thomas R | EVP, Chief Commercial Officer | Nov 30, 2015 | Option Exercise | $2.03 | 5,091 | 10,335 | 5,091 | Feb 04, 2016, 12:06 PM |
Menu